These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 18596942)

  • 1. Cerebrospinal fluid B cells correlate with early brain inflammation in multiple sclerosis.
    Kuenz B; Lutterotti A; Ehling R; Gneiss C; Haemmerle M; Rainer C; Deisenhammer F; Schocke M; Berger T; Reindl M
    PLoS One; 2008 Jul; 3(7):e2559. PubMed ID: 18596942
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cerebrospinal fluid B cells and disease progression in multiple sclerosis - A longitudinal prospective study.
    Wurth S; Kuenz B; Bsteh G; Ehling R; Di Pauli F; Hegen H; Auer M; Gredler V; Deisenhammer F; Reindl M; Berger T
    PLoS One; 2017; 12(8):e0182462. PubMed ID: 28777826
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glial and neuroaxonal biomarkers in a multiple sclerosis (MS) cohort.
    Kalatha T; Hatzifilippou E; Arnaoutoglou M; Balogiannis S; Koutsouraki E
    Hell J Nucl Med; 2019; 22 Suppl 2():113-121. PubMed ID: 31802051
    [TBL] [Abstract][Full Text] [Related]  

  • 4. B cells undergo unique compartmentalized redistribution in multiple sclerosis.
    Haas J; Bekeredjian-Ding I; Milkova M; Balint B; Schwarz A; Korporal M; Jarius S; Fritz B; Lorenz HM; Wildemann B
    J Autoimmun; 2011 Dec; 37(4):289-99. PubMed ID: 21924866
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The chemokine CXCL13 is a prognostic marker in clinically isolated syndrome (CIS).
    Brettschneider J; Czerwoniak A; Senel M; Fang L; Kassubek J; Pinkhardt E; Lauda F; Kapfer T; Jesse S; Lehmensiek V; Ludolph AC; Otto M; Tumani H
    PLoS One; 2010 Aug; 5(8):e11986. PubMed ID: 20700489
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased expression of B7-1 costimulatory molecule on cerebrospinal fluid cells of patients with multiple sclerosis and infectious central nervous system disease.
    Svenningsson A; Dotevall L; Stemme S; Andersen O
    J Neuroimmunol; 1997 May; 75(1-2):59-68. PubMed ID: 9143238
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cerebrospinal fluid markers reveal intrathecal inflammation in progressive multiple sclerosis.
    Komori M; Blake A; Greenwood M; Lin YC; Kosa P; Ghazali D; Winokur P; Natrajan M; Wuest SC; Romm E; Panackal AA; Williamson PR; Wu T; Bielekova B
    Ann Neurol; 2015 Jul; 78(1):3-20. PubMed ID: 25808056
    [TBL] [Abstract][Full Text] [Related]  

  • 8. BAFF Index and CXCL13 levels in the cerebrospinal fluid associate respectively with intrathecal IgG synthesis and cortical atrophy in multiple sclerosis at clinical onset.
    Puthenparampil M; Federle L; Miante S; Zito A; Toffanin E; Ruggero S; Ermani M; Pravato S; Poggiali D; Perini P; Rinaldi F; Gallo P
    J Neuroinflammation; 2017 Jan; 14(1):11. PubMed ID: 28095856
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A pathogenic and clonally expanded B cell transcriptome in active multiple sclerosis.
    Ramesh A; Schubert RD; Greenfield AL; Dandekar R; Loudermilk R; Sabatino JJ; Koelzer MT; Tran EB; Koshal K; Kim K; Pröbstel AK; Banerji D; ; Guo CY; Green AJ; Bove RM; DeRisi JL; Gelfand JM; Cree BAC; Zamvil SS; Baranzini SE; Hauser SL; Wilson MR
    Proc Natl Acad Sci U S A; 2020 Sep; 117(37):22932-22943. PubMed ID: 32859762
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cerebrospinal fluid anti-myelin antibodies are related to magnetic resonance measures of disease activity in multiple sclerosis.
    Vogt MH; Teunissen CE; Iacobaeus E; Heijnen DA; Breij EC; Olsson T; Brundin L; Killestein J; Dijkstra CD
    J Neurol Neurosurg Psychiatry; 2009 Oct; 80(10):1110-5. PubMed ID: 18931010
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clonal relationships of CSF B cells in treatment-naive multiple sclerosis patients.
    Eggers EL; Michel BA; Wu H; Wang SZ; Bevan CJ; Abounasr A; Pierson NS; Bischof A; Kazer M; Leitner E; Greenfield AL; Demuth S; Wilson MR; Henry RG; Cree BA; Hauser SL; von Büdingen HC
    JCI Insight; 2017 Nov; 2(22):. PubMed ID: 29202449
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intrathecal production of Chlamydia pneumoniae-specific high-affinity antibodies is significantly associated to a subset of multiple sclerosis patients with progressive forms.
    Fainardi E; Castellazzi M; Casetta I; Cultrera R; Vaghi L; Granieri E; Contini C
    J Neurol Sci; 2004 Feb; 217(2):181-8. PubMed ID: 14706222
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Features of intrathecal immunoglobulins in patients with multiple sclerosis.
    Di Pauli F; Gredler V; Kuenz B; Lutterotti A; Ehling R; Gneiss C; Schocke M; Deisenhammer F; Reindl M; Berger T
    J Neurol Sci; 2010 Jan; 288(1-2):147-50. PubMed ID: 19828154
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cerebrospinal fluid immunoglobulin light chain ratios predict disease progression in multiple sclerosis.
    Rathbone E; Durant L; Kinsella J; Parker AR; Hassan-Smith G; Douglas MR; Curnow SJ
    J Neurol Neurosurg Psychiatry; 2018 Oct; 89(10):1044-1049. PubMed ID: 29743290
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative analysis of the CD19+ and CD138+ cell antibody repertoires in the cerebrospinal fluid of patients with multiple sclerosis.
    Ritchie AM; Gilden DH; Williamson RA; Burgoon MP; Yu X; Helm K; Corboy JR; Owens GP
    J Immunol; 2004 Jul; 173(1):649-56. PubMed ID: 15210828
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biomarkers of inflammation and axonal degeneration/damage in patients with newly diagnosed multiple sclerosis: contributions of the soluble CD163 CSF/serum ratio to a biomarker panel.
    Stilund M; Gjelstrup MC; Petersen T; Møller HJ; Rasmussen PV; Christensen T
    PLoS One; 2015; 10(4):e0119681. PubMed ID: 25860354
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic value of free light chains lambda and kappa in early multiple sclerosis.
    Voortman MM; Stojakovic T; Pirpamer L; Jehna M; Langkammer C; Scharnagl H; Reindl M; Ropele S; Seifert-Held T; Archelos JJ; Fuchs S; Enzinger C; Fazekas F; Khalil M
    Mult Scler; 2017 Oct; 23(11):1496-1505. PubMed ID: 27899552
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased cerebrospinal fluid concentrations of the chemokine CXCL13 in active MS.
    Sellebjerg F; Börnsen L; Khademi M; Krakauer M; Olsson T; Frederiksen JL; Sørensen PS
    Neurology; 2009 Dec; 73(23):2003-10. PubMed ID: 19996075
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sulfatide isoform pattern in cerebrospinal fluid discriminates progressive MS from relapsing-remitting MS.
    Novakova L; Singh AK; Axelsson M; Ståhlman M; Adiels M; Malmeström C; Zetterberg H; Borén J; Lycke J; Cardell SL; Blomqvist M
    J Neurochem; 2018 Aug; 146(3):322-332. PubMed ID: 29676479
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Flow cytometric analysis of T cell/monocyte ratio in clinically isolated syndrome identifies patients at risk of rapid disease progression.
    Nemecek A; Zimmermann H; Rübenthaler J; Fleischer V; Paterka M; Luessi F; Müller-Forell W; Zipp F; Siffrin V
    Mult Scler; 2016 Apr; 22(4):483-93. PubMed ID: 26163073
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.